Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Dupixent
Dupixent
Incyte, itching for a piece of Dupixent's market, hits goals in midphase skin disease trial
Fierce Biotech
Mon, 03/11/24 - 11:52 am
Incyte
clinical trials
prurigo nodularis
povorcitinib
Dupixent
Sanofi
Regeneron
Takeda’s Eohilia to compete Sanofi’s Dupixent in eosinophilic esophagitis treatment
Clinical Trials Arena
Thu, 02/29/24 - 11:11 am
Takeda
Eohilia
Sanofi
Dupixent
EoE
eosinophilic esophagitis
Sanofi, Regeneron Secure FDA Priority Review for Dupixent in COPD
BioSpace
Fri, 02/23/24 - 10:43 am
FDA
Sanofi
Regeneron
Dupixent
priority review
COPD
Could Dupixent find a new life targeting ‘memory’ B cells to treat allergies?
Fierce Biotech
Fri, 02/9/24 - 11:20 am
allergies
Dupixent
Sanofi
Sanofi Q4 earnings hit by weak dollar, generic competition
Reuters
Thu, 02/1/24 - 11:25 am
Sanofi
earnings
Dupixent
Aubagio
Sanofi, Regeneron Win Dupixent Label Expansion to Treat Eosinophilic Esophagitis
BioSpace
Fri, 01/26/24 - 11:19 am
Regeneron
Sanofi
Dupixent
eosinic esophagitis
pediatric
FDA
FDA updates Sanofi’s Dupixent label for atopic dermatitis
Pharmaceutical Business Review
Wed, 01/17/24 - 09:26 am
Sanofi
Dupixent
FDA
atopic dermatitis
Dupixent for cancer? Researchers test blockbuster med as an immunotherapy-booster
Fierce Biotech
Thu, 12/7/23 - 11:13 pm
Regeneron
Sanofi
Dupixent
cancer
lung cancer
Sanofi, Regeneron eye Dupixent label expansion with promising COPD data
Medical Marketing and Media
Tue, 11/28/23 - 10:27 am
Sanofi
Regeneron
Dupixent
clinical trials
COPD
Regeneron beats quarterly profit estimates on eczema treatment strength
Reuters
Thu, 11/2/23 - 11:33 am
Regeneron
earnings
Dupixent
Sanofi reports positive data from Phase III trial of Dupixent
Clinical Trials Arena
Tue, 10/24/23 - 09:51 am
Sanofi
clinical trials
Dupixent
eosinophilic esophagitis
pediatric
Dupixent returns as top Rx, OTC brand for September
Medical Marketing and Media
Tue, 10/17/23 - 09:41 pm
Sanofi
Regeneron
Dupixent
DTC ads
pharma ads
Scratching the surface of the urticaria pipeline
EP Vantage
Thu, 07/20/23 - 10:00 am
chronic urticaria
Sanofi
Dupixent
Regeneron
Novartis
Roche
Xolair
Allakos
AstraZeneca
Celldex Therapeutics
Dupixent goes back-to-back as top Rx, OTC pharma brand in June
Medical Marketing and Media
Thu, 07/6/23 - 10:16 am
Dupixent
Sanofi
Regeneron
Aslan sells Japanese rights to would-be Dupixent rival for $12M
Fierce Biotech
Thu, 06/22/23 - 10:41 pm
Aslan
Dupixent
Japan
eczema
Sanofi
Regeneron
eblasakimab
Dupixent reclaims throne as top Rx, OTC pharma brand in May
Medical Marketing and Media
Tue, 06/6/23 - 11:13 am
Dupixent
Sanofi
Regeneron
DTC advertising
Sanofi, Regeneron flesh out COPD data with Dupixent
Pharmaphorum
Mon, 05/22/23 - 10:16 am
Sanofi
Regeneron
COPD
Dupixent
Revolo drops dab of midphase data on would-be Dupixent rival
Fierce Biotech
Wed, 04/19/23 - 10:11 am
Revolo Biotherapeutics
clinical trials
allergies
Dupixent
Sanofi, Regeneron's Dupixent could hit $20B in peak sales with COPD expansion: analyst
Fierce Pharma
Sun, 03/26/23 - 11:30 pm
Sanofi
Regeneron
Dupixent
COPD
Sanofi and Regeneron's Dupixent scores trial win in tough-to-treat COPD
Fierce Pharma
Thu, 03/23/23 - 11:44 am
Sanofi
Regeneron
Dupixent
COPD
clinical trials
Pages
1
2
3
4
5
6
7
next ›
last »